Drug
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
Novo Nordisk has made a bid worth up to USD 9 billion for the American company Metsera – just...
New license agreement complements strong quarter for Orion
Despite challenging comparative figures, Orion delivered a stable underlying...
New major investment will strengthen Europe's life science sector
Europe takes a new step to strengthen...
Strong growth and successful acquisitions drive MedCap
Life science company MedCap reports strong revenue growth during...
Shaping tomorrow, today – Breakthrough T1D Mission Summit
At the Breakthrough T1D Mission Summit in Miami on...
SwedenBIO's CEO: How Sweden can strengthen its role in drug manufacturing and clinical trials
With a strong research base and globally recognized innovations...
Focused investments in the cards for Flerie
Life science investor Flerie reports a net asset value of 3...
Mass defections in Novo board after disagreement with major owner
Almost the entire board of Novo Nordisk resigns after...
News wave from AstraZeneca in connection with ESMO 2025
AstraZeneca delivered a series of positive news during the ESMO Congress...
Enzymatica launches new ColdZyme flavour
Enzymatica broadens its product range with a new flavor...
Fluicell marks major milestones
In just a month or so, Mölndal-based Fluicell has adopted...
The bid for Bavarian Nordic meets stiff resistance
Danish vaccine pioneer Bavarian Nordic is involved in...